Overexpression of IRF7 increased IFN-β production and thus significantly enhanced NK cell activity, leading to cytolysis of prostate cancer target cells and exerting an inhibitory effect on bone metastasis of prostate cancer. Here, IRF7 is linked to prostate cancer.